MoonLake Immunotherapeutics (MLTX)
52.17
+0.29
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
52.27
+0.10
(+0.19%)
After-Hours: 20:00
MoonLake Immunotherapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Novartis AG | 0.6999 |
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | 0.00 |
| NLS Pharmaceutics Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 518.21M |
| Total Liabilities (Quarterly) | 22.71M |
| Shareholders Equity (Quarterly) | 488.20M |